专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060019986A1 (R/S) rifamycin derivatives, their preparations and pharmaceutical compositions 有权
标题翻译：（R / S）利福霉素衍生物，其制剂和药物组合物
公开(公告)号：US20060019986A1
公开(公告)日：2006-01-26
申请号：US11186425
申请日：2005-07-21
申请人： Charles Ding , Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith Minor , In Kim , Jamie Longgood , Yafei Jin , Keith Combrink
发明人： Charles Ding , Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith Minor , In Kim , Jamie Longgood , Yafei Jin , Keith Combrink
IPC分类号： A61K31/4745 , C07D491/14
CPC分类号： C07D401/12 , C07D455/02
摘要： Rifamycin derivatives having the following structure of general formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or its salts, hydrates or prodrugs thereof; wherein a preferred R1 comprises hydrogen or acetyl and a prefered R2 comprises hydrogen, methyl or other lower alkyls; wherein asterik (*) denotes the carbon bearing the chiral center, wherein absolute configuration is assigned as R or S. Methods of preparation of the aforementioned rifamycin derivatives are also described. The compounds exhibit antimicrobial activities, including activities against drug-resistant microorganisms.
摘要翻译：具有以下通式I结构的利福霉素衍生物（氢醌和对应的醌（C 1 -C 4））形成）：或其盐，水合物或前药; 其中优选的R 1包括氢或乙酰基，优选的R 2 H 2包括氢，甲基或其它低级烷基; 其中asterik（*）表示带有手性中心的碳，其中绝对构型被指定为R或S.还描述了上述利福霉素衍生物的制备方法。这些化合物表现出抗菌活性，包括抵抗耐药微生物的活性。

2. 发明申请

US20060019985A1 Rifamycin derivatives 有权
标题翻译：利福霉素衍生物
公开(公告)号：US20060019985A1
公开(公告)日：2006-01-26
申请号：US11186187
申请日：2005-07-21
申请人： Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith Minor , In Kim , Charles Ding , Jamie Longgood , Yafei Jin , Keith Combrink
发明人： Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith Minor , In Kim , Charles Ding , Jamie Longgood , Yafei Jin , Keith Combrink
IPC分类号： A61K31/4745 , C07D491/14
CPC分类号： C07D401/12 , C07D455/02
摘要： Novel rifamycin derivatives of formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or their salts, hydrates or prodrugs thereof, wherein: a preferred R comprises hydrogen, acetyl; L is a linker, a preferred linker group elements selected from any combination of 1 to 5 groups shown FIG. 1, provided L is not wherein R1 is H, methyl or alkyl. The inventive compounds exhibit valuable antibiotic properties. Formulations having these compounds can be used in the control or prevention of infectious diseases in mammals, both humans and non-humans. In particular, the compounds exhibit a pronounced antibacterial activity, even against multiresistant strains of microbes.
摘要翻译：式I的新型利福霉素衍生物（氢醌和相应的醌（C 1 -C 4））形成）：或其盐，水合物或前药，其中：优选的R 包括氢，乙酰基; L是接头，优选的连接基团元素选自1至5个组的任何组合，如图1所示。 1，其中L不是其中R 1是H，甲基或烷基。本发明化合物显示出有价值的抗生素性质。具有这些化合物的制剂可以用于控制或预防哺乳动物，包括人和非人的感染性疾病。特别地，这些化合物甚至显示出显着的抗菌活性，即使是针对多抗菌菌株的微生物。

3. 发明授权

US07226931B2 (R/S) rifamycin derivatives, their preparations and pharmaceutical compositions 有权
标题翻译：（R / S）利福霉素衍生物，其制剂和药物组合物
公开(公告)号：US07226931B2
公开(公告)日：2007-06-05
申请号：US11186425
申请日：2005-07-21
申请人： Charles Z. Ding , Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith P. Minor , In Ho Kim , Jamie C. Longgood , Yafei Jin , Keith D. Combrink
发明人： Charles Z. Ding , Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith P. Minor , In Ho Kim , Jamie C. Longgood , Yafei Jin , Keith D. Combrink
IPC分类号： C07D498/08 , A61K31/4709 , A61P31/04
CPC分类号： C07D401/12 , C07D455/02
摘要： Rifamycin derivatives having the following structure of general formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or its salts, hydrates or prodrugs thereof; wherein a preferred R1 comprises hydrogen or acetyl and a prefered R2 comprises hydrogen, methyl or other lower alkyls; wherein asterik (*) denotes the carbon bearing the chiral center, wherein absolute configuration is assigned as R or S. Methods of preparation of the aforementioned rifamycin derivatives are also described. The compounds exhibit antimicrobial activities, including activities against drug-resistant microorganisms.
摘要翻译：具有以下通式I结构的利福霉素衍生物（氢醌和对应的醌（C 1 -C 4））形成）：或其盐，水合物或前药; 其中优选的R 1包括氢或乙酰基，优选的R 2 H 2包括氢，甲基或其它低级烷基; 其中asterik（*）表示带有手性中心的碳，其中绝对构型被指定为R或S.还描述了上述利福霉素衍生物的制备方法。这些化合物表现出抗菌活性，包括抵抗耐药微生物的活性。

4. 发明授权

US07229996B2 Rifamycin derivatives 有权
标题翻译：利福霉素衍生物
公开(公告)号：US07229996B2
公开(公告)日：2007-06-12
申请号：US11186187
申请日：2005-07-21
申请人： Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith P. Minor , In Ho Kim , Charles Z. Ding , Jamie C. Longgood , Yafei Jin , Keith D. Combrink
发明人： Zhenkun Ma , Jing Li , Susan Harran , Yong He , Keith P. Minor , In Ho Kim , Charles Z. Ding , Jamie C. Longgood , Yafei Jin , Keith D. Combrink
IPC分类号： C07D498/08 , A61K31/4709 , A61P31/04
CPC分类号： C07D401/12 , C07D455/02
摘要： Novel rifamycin derivatives of formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or their salts, hydrates or prodrugs thereof, wherein: a preferred R comprises hydrogen, acetyl; L is a linker, a preferred linker group elements selected from any combination of 1 to 5 groups shown FIG. 1, provided L is not wherein R1 is H, methyl or alkyl. The inventive compounds exhibit valuable antibiotic properties. Formulations having these compounds can be used in the control or prevention of infectious diseases in mammals, both humans and non-humans. In particular, the compounds exhibit a pronounced antibacterial activity, even against multiresistant strains of microbes.
摘要翻译：式I的新型利福霉素衍生物（氢醌和相应的醌（C 1 -C 4））形成）：或其盐，水合物或前药，其中：优选的R 包括氢，乙酰基; L是接头，优选的连接基团元素选自1至5个组的任何组合，如图1所示。 1，其中L不是其中R 1是H，甲基或烷基。本发明化合物显示出有价值的抗生素性质。具有这些化合物的制剂可以用于控制或预防哺乳动物，包括人和非人的感染性疾病。特别地，这些化合物甚至显示出显着的抗菌活性，即使是针对多抗菌菌株的微生物。

5. 外观设计

USD962577S1 Trash can 有权
公开(公告)号：USD962577S1
公开(公告)日：2022-08-30
申请号：US29799298
申请日：2021-07-13
申请人： Yong He
设计人： Yong He

6. 发明申请

US20140051467A1 Spectrum Allocation for Base Station 有权
标题翻译：基站频谱分配
公开(公告)号：US20140051467A1
公开(公告)日：2014-02-20
申请号：US13202297
申请日：2011-05-04
申请人： Kun Tan , Jiansong Zhang , Yongguang Zhang , Ranveer Chandra , Yong He , Thomas Moscibroda , Paramvir Bahl , Haichen Shen
发明人： Kun Tan , Jiansong Zhang , Yongguang Zhang , Ranveer Chandra , Yong He , Thomas Moscibroda , Paramvir Bahl , Haichen Shen
IPC分类号： H04W72/08 , H04W72/04 , H04W88/08
CPC分类号： H04W72/0453 , H04L5/0005 , H04L5/0023 , H04L5/0064 , H04L5/0066 , H04L5/0092 , H04L5/14 , H04L27/0006 , H04W16/14 , H04W72/0446 , H04W72/082 , H04W88/08
摘要： Embodiments include processes, systems, and devices that allow a white space base station to request available frequency ranges for white space transmission in a local area. A white space finder service models a primary user device's transmission signal propagation area using terrain data associated with the local area of the primary user device. The white space finder service also determines, based on the location of the white space base station and the modeled propagation area, one or more locally available, non-interfering frequency ranges and provides them to the white space base station. The white space base station compares the provided frequency ranges to policies and selects one or more of the available frequencies that accommodate the policies. The white space base station also maps the transmission frequency ranges to virtual frequency ranges for transmission by a software-defined radio employing spectrum virtualization.
摘要翻译：实施例包括允许空白基站在局部区域中为空白传输请求可用频率范围的过程，系统和设备。白色空间查找器服务使用与主用户设备的本地区域相关联的地形数据来建模主用户设备的传输信号传播区域。白色空间查找器服务还基于白色空间基站的位置和建模的传播区域确定一个或多个本地可用的非干扰频率范围并将其提供给空白基站。空白基站将提供的频率范围与策略进行比较，并选择适应策略的一个或多个可用频率。白空间基站还将传输频率范围映射到虚拟频率范围，以便通过使用频谱虚拟化的软件定义无线电进行传输。

7. 发明授权

US08350033B2 4-((3, 5, 6-trimethylpyrazine-2-yl) methoxyl) benzoic acid and its derivatives 失效
标题翻译： 4 - （（3,5,6-三甲基吡嗪-2-基）甲氧基）苯甲酸及其衍生物
公开(公告)号：US08350033B2
公开(公告)日：2013-01-08
申请号：US12681623
申请日：2008-10-27
申请人： Jiaming Li , Guangwei He , Yonghai Zhao , Fengshi Ma , Yong He , Qiang Wu , Feng Li
发明人： Jiaming Li , Guangwei He , Yonghai Zhao , Fengshi Ma , Yong He , Qiang Wu , Feng Li
IPC分类号： C07D241/00
CPC分类号： C07D241/12
摘要： Ligustrazine aromatic acid ether derivative of general formula I, its preparation method, pharmaceutical composition and application, wherein Ar is selected from aryl substituted aryl and substituted styryl, R is selected from hydrogen and alkyl with no more than 6 carbon atoms.
摘要翻译：通式I的ustr嗪芳香醚衍生物，其制备方法，药物组合物和应用，其中Ar选自芳基取代的芳基和取代的苯乙烯基，R选自氢和不超过6个碳原子的烷基。

8. 发明授权

US08224384B2 Methods, systems, and computer program products for oversubscription of wireless media gateway resources 有权
标题翻译：方法，系统和计算机程序产品用于超量订阅无线媒体网关资源
公开(公告)号：US08224384B2
公开(公告)日：2012-07-17
申请号：US11711505
申请日：2007-02-27
申请人： San-qi Li , Hao Hou , Yong He
发明人： San-qi Li , Hao Hou , Yong He
IPC分类号： H04B1/38
CPC分类号： H04W28/16 , H04W88/16
摘要： The subject matter described herein includes methods, systems, and computer program products for oversubscription of wireless media gateway resources. According to one aspect, the subject matter described herein includes a method for oversubscription of wireless media gateway resources. The method includes defining at least one per-resource oversubscription factor for wireless media gateway resources required by at least one wireless network connection. The wireless media gateway resources are provisioned for the at least one wireless network connection using the at least one per-resource oversubscription factor. Allocating the wireless media gateway resources to the at least one wireless connection network includes oversubscribing the wireless media gateway resources by an amount based on the at least one per-resource oversubscription factor to increase utilization of the wireless media gateway resources by increasing the number of wireless network connections that the wireless media gateway is capable of serving.
摘要翻译：本文描述的主题包括用于超额预订无线媒体网关资源的方法，系统和计算机程序产品。根据一个方面，本文描述的主题包括用于超量订阅无线媒体网关资源的方法。该方法包括为至少一个无线网络连接所需的无线媒体网关资源定义至少一个每资源超额订阅因子。使用至少一个每资源超额预订因子为无线网络连接提供无线媒体网关资源。将无线媒体网关资源分配给至少一个无线连接网络包括基于至少一个每资源超额预订因子超额订阅无线媒体网关资源的量，以通过增加无线媒体网关资源的数量来增加无线媒体网关资源的利用无线媒体网关能够提供的网络连接。

9. 发明申请

US20120127969A1 SEMI-RANDOM BACK-OFF METHOD FOR ACHIEVING RESOURCE RESERVATION IN WIRELESS LOCAL AREA NETWORKS 有权
标题翻译：用于在无线局域网中实现资源预留的半随机备用方法
公开(公告)号：US20120127969A1
公开(公告)日：2012-05-24
申请号：US13386923
申请日：2010-07-13
申请人： Yong He , Xiao-jun Ma , Jun Li
发明人： Yong He , Xiao-jun Ma , Jun Li
IPC分类号： H04W72/04
CPC分类号： H04W74/085
摘要： A method and apparatus are described including determining if a successful unicast transmission has occurred, adjusting a contention window to a minimum value and adjusting a time slot back-off counter to one-half of the value of the contention window plus one responsive to the determination and adjusting the contention window using one of a plurality of adjustment schemes and selecting said time slot back-off counter from an interval between zero and the contention window.
摘要翻译：描述了一种方法和装置，包括确定是否已经发生了成功的单播传输，将竞争窗口调整到最小值并且将响应于该确定的竞争窗口值的一半调整到时隙退避计数器的一半以及使用多个调整方案中的一个调整所述争用窗口，并且从所述争用窗口之间的间隔中选择所述时隙退避计数器。

10. 发明申请

US20100265864A1 Method and apparatus for power management in communication system 审中-公开
标题翻译：通信系统电源管理方法与装置
公开(公告)号：US20100265864A1
公开(公告)日：2010-10-21
申请号：US12802432
申请日：2010-06-07
申请人： Yong He , Xiao Jin Ma , Huan Qiang Zhang , Jun Ll , Charles Chuanming Wang
发明人： Yong He , Xiao Jin Ma , Huan Qiang Zhang , Jun Ll , Charles Chuanming Wang
IPC分类号： H04W52/02
CPC分类号： H04W68/025 , H04L12/189 , H04W4/06
摘要： A method and apparatus for power management in the communication system, wherein the method for transmitting data from an access point to communication units comprising: assigning, by the access point, a first and a second association identifier in a message, to each of the communication units, to indicate the presence of respective buffered multicast data and unicast data respectively; setting, by the access point, the first association identifier to indicate the corresponding communication unit to receive the buffered multicast data, the second association identifier to indicate the corresponding communication unit to receive the buffered unicast data; and transmitting, by the access point, the message to awake the communication unit corresponding to the set first and/or second association identifier so as to transmit the buffered data thereto.
摘要翻译：一种用于在通信系统中进行功率管理的方法和装置，其中用于从接入点向通信单元发送数据的方法包括：由接入点将消息中的第一和第二关联标识符分配给每个通信单元，分别指示各个缓冲的组播数据和单播数据的存在; 由所述接入点设置所述第一关联标识符以指示相应的通信单元以接收缓冲的多播数据，所述第二关联标识符用于指示相应的通信单元以接收所缓存的单播数据; 以及由所述接入点发送所述消息以唤醒与所设置的第一和/或第二关联标识符对应的所述通信单元，以将所缓存的数据发送到所述第一和/或第二关联标识符。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式